Retrieval augmented scientific claim verification.

TitleRetrieval augmented scientific claim verification.
Publication TypeJournal Article
Year of Publication2024
AuthorsLiu H, Soroush A, Nestor JG, Park E, Idnay B, Fang Y, Pan J, Liao S, Bernard M, Peng Y, Weng C
JournalJAMIA Open
Volume7
Issue1
Paginationooae021
Date Published2024 Apr
ISSN2574-2531
Abstract

OBJECTIVE: To automate scientific claim verification using PubMed abstracts.

MATERIALS AND METHODS: We developed CliVER, an end-to-end scientific Claim VERification system that leverages retrieval-augmented techniques to automatically retrieve relevant clinical trial abstracts, extract pertinent sentences, and use the PICO framework to support or refute a scientific claim. We also created an ensemble of three state-of-the-art deep learning models to classify rationale of support, refute, and neutral. We then constructed CoVERt, a new COVID VERification dataset comprising 15 PICO-encoded drug claims accompanied by 96 manually selected and labeled clinical trial abstracts that either support or refute each claim. We used CoVERt and SciFact (a public scientific claim verification dataset) to assess CliVER's performance in predicting labels. Finally, we compared CliVER to clinicians in the verification of 19 claims from 6 disease domains, using 189 648 PubMed abstracts extracted from January 2010 to October 2021.

RESULTS: In the evaluation of label prediction accuracy on CoVERt, CliVER achieved a notable F1 score of 0.92, highlighting the efficacy of the retrieval-augmented models. The ensemble model outperforms each individual state-of-the-art model by an absolute increase from 3% to 11% in the F1 score. Moreover, when compared with four clinicians, CliVER achieved a precision of 79.0% for abstract retrieval, 67.4% for sentence selection, and 63.2% for label prediction, respectively.

CONCLUSION: CliVER demonstrates its early potential to automate scientific claim verification using retrieval-augmented strategies to harness the wealth of clinical trial abstracts in PubMed. Future studies are warranted to further test its clinical utility.

DOI10.1093/jamiaopen/ooae021
Alternate JournalJAMIA Open
PubMed ID38455840
PubMed Central IDPMC10919922
Grant ListT15 LM007079 / LM / NLM NIH HHS / United States
R01 LM009886 / LM / NLM NIH HHS / United States
R01 LM014344 / LM / NLM NIH HHS / United States
P30 AG066462 / AG / NIA NIH HHS / United States
R01 LM013061 / LM / NLM NIH HHS / United States